World Pharma News

15

Sep2015
Shares of Mylan are edging up before the opening bell after the pharmaceutical company went ahead with its hostile, $27.14 ... Read More

15

Sep2015
- GBR 1302, a HER2xCD3 bi-specific antibody has successfully completed the preclinical evaluation phase - Preclinically, GBR 1302 has demonstrated superiority ... Read More

15

Sep2015
Raptor Pharmaceutical said that its RP103 (cysteamine bitartrate) drug failed to meet the main goal in a second mid-stage study. The ... Read More

15

Sep2015
LONDON— Roche Holding AG is unlikely to pursue midsize acquisitions soon because companies with drugs in late-stage development are too ... Read More